DXB vs ECS

ASX Healthcare sector comparison — updated 22 Jul 2026 — Healthcare sector

DXB

DIMERIX FPO [DXB]

42LOW

ECS

ECSBOTANIC FPO [ECS]

45LOW

Score Breakdown

DXB ECS
Technical
39
31
Catalyst
53
52
Sentiment
50
50
Fundamental
82
61
Momentum
44
57
Risk Gate
50
27

Key Metrics

DXB Metric ECS
$135.1MMarket Cap$9.6M
2.6MAvg Volume (20d)1.9M
N/AShort InterestN/A
$0.66552-Week High$0.010
$0.15852-Week Low$0.003
+2.2%Daily Change-16.7%
$0.230Reference Price$0.005
-594.5%ROEN/A
-219.9%Profit MarginN/A

Active Signals

DXB Signals

●MACD momentum is losing steam
●Drifting lower — down 4.2% over the last 5 days
●Beating the Small Ords index — relative strength of 1.24, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Strong revenue growth (+636%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (13% of range)

ECS Signals

●Stochastic turning bearish from a high level — caution
●Volume surging at 6.3x normal while price falls — heavy selling pressure
●Beating the Small Ords index — relative strength of 1.17, so it's outpacing the pack
●Volatility is expanding fast — choppy price action, so buckle up
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (16 quarters)
●4C filed 2026-07-19
●Very high P/S ratio (2653.7x)

Ask Scout AI to compare DXB and ECS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

DXB vs ENL →DXB vs EPN →DXB vs EZZ →DXB vs HIQ →DXB vs ILA →
DXB Full Analysis → ECS Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).